RKDA - Arcadia Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 3/9/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
34.84M24.66M47.38M40.46M19.24M
Enterprise Value 3
6.14M1.57M18.68M22.64M3.79M
Trailing P/E
N/AN/AN/A4.63N/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
18.1615.5124.6919.329.62
Price/Book (mrq)
2.573.203.504.8830.39
Enterprise Value/Revenue 3
5.135.0844.9157.7618.68
Enterprise Value/EBITDA 6
-0.270.57-3.07-1.62-0.80

Trading Information

Stock Price History

Beta (5Y Monthly) -0.83
52-Week Change 316.02%
S&P500 52-Week Change 35.67%
52 Week High 310.2000
52 Week Low 31.8200
50-Day Moving Average 33.9096
200-Day Moving Average 34.1929

Share Statistics

Avg Vol (3 month) 3235.75k
Avg Vol (10 day) 3164.99k
Shares Outstanding 510.05M
Float 7.01M
% Held by Insiders 119.04%
% Held by Institutions 113.04%
Shares Short (Jun 14, 2020) 4291.2k
Short Ratio (Jun 14, 2020) 41.24
Short % of Float (Jun 14, 2020) 43.29%
Short % of Shares Outstanding (Jun 14, 2020) 42.90%
Shares Short (prior month May 14, 2020) 4600.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,663.11%

Management Effectiveness

Return on Assets (ttm)-50.63%
Return on Equity (ttm)-215.28%

Income Statement

Revenue (ttm)1.32M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)95.60%
Gross Profit (ttm)-6.81M
EBITDA -21.72M
Net Income Avi to Common (ttm)-13.67M
Diluted EPS (ttm)-1.8660
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.02M
Total Cash Per Share (mrq)1.85
Total Debt (mrq)6M
Total Debt/Equity (mrq)49.08
Current Ratio (mrq)4.09
Book Value Per Share (mrq)1.27

Cash Flow Statement

Operating Cash Flow (ttm)-22.5M
Levered Free Cash Flow (ttm)-15.87M